Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

'How far' vs 'how fast' in Alzheimer's disease. The question revisited.

Kraemer HC, Tinklenberg J, Yesavage JA.

Arch Neurol. 1994 Mar;51(3):275-9.

PMID:
8129639
[PubMed - indexed for MEDLINE]
2.

The prognosis in Alzheimer's disease. 'How far' rather than 'how fast' best predicts the course.

Drachman DA, O'Donnell BF, Lew RA, Swearer JM.

Arch Neurol. 1990 Aug;47(8):851-6.

PMID:
2375690
[PubMed - indexed for MEDLINE]
3.

Extrapyramidal signs and psychiatric symptoms predict faster cognitive decline in Alzheimer's disease.

Chui HC, Lyness SA, Sobel E, Schneider LS.

Arch Neurol. 1994 Jul;51(7):676-81.

PMID:
8018040
[PubMed - indexed for MEDLINE]
4.

Development of aphasia, apraxia, and agnosia and decline in Alzheimer's disease.

Yesavage JA, Brooks JO 3rd, Taylor J, Tinklenberg J.

Am J Psychiatry. 1993 May;150(5):742-7.

PMID:
8480819
[PubMed - indexed for MEDLINE]
5.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
[PubMed - indexed for MEDLINE]
6.

Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up.

Devanand DP, Michaels-Marston KS, Liu X, Pelton GH, Padilla M, Marder K, Bell K, Stern Y, Mayeux R.

Am J Psychiatry. 2000 Sep;157(9):1399-405.

PMID:
10964854
[PubMed - indexed for MEDLINE]
7.

Predicting time to nursing home care and death in individuals with Alzheimer disease.

Stern Y, Tang MX, Albert MS, Brandt J, Jacobs DM, Bell K, Marder K, Sano M, Devanand D, Albert SM, Bylsma F, Tsai WY.

JAMA. 1997 Mar 12;277(10):806-12.

PMID:
9052710
[PubMed - indexed for MEDLINE]
8.

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease.

Lopez OL, Wisniewski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1999 Oct;56(10):1266-72.

PMID:
10520944
[PubMed - indexed for MEDLINE]
9.

Extrapyramidal signs in patients with probable Alzheimer disease.

Lopez OL, Wisnieski SR, Becker JT, Boller F, DeKosky ST.

Arch Neurol. 1997 Aug;54(8):969-75.

PMID:
9267971
[PubMed - indexed for MEDLINE]
10.

Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study.

Stern Y, Albert M, Brandt J, Jacobs DM, Tang MX, Marder K, Bell K, Sano M, Devanand DP, Bylsma F, et al.

Neurology. 1994 Dec;44(12):2300-7.

PMID:
7991116
[PubMed - indexed for MEDLINE]
11.

A method for estimating progression rates in Alzheimer disease.

Doody RS, Massman P, Dunn JK.

Arch Neurol. 2001 Mar;58(3):449-54.

PMID:
11255449
[PubMed - indexed for MEDLINE]
12.

Factors affecting course and survival in Alzheimer's disease. A 9-year longitudinal study.

Bracco L, Gallato R, Grigoletto F, Lippi A, Lepore V, Bino G, Lazzaro MP, Carella F, Piccolo T, Pozzilli C, et al.

Arch Neurol. 1994 Dec;51(12):1213-9.

PMID:
7986176
[PubMed - indexed for MEDLINE]
13.

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part XI. Clinical milestones in patients with Alzheimer's disease followed over 3 years.

Galasko D, Edland SD, Morris JC, Clark C, Mohs R, Koss E.

Neurology. 1995 Aug;45(8):1451-5.

PMID:
7644039
[PubMed - indexed for MEDLINE]
14.

[Predictors of long-term institutionalization in patients with Alzheimer's disease: role of caregiver burden].

Hirono N, Tsukamoto N, Inoue M, Moriwaki Y, Mori E.

No To Shinkei. 2002 Sep;54(9):812-8. Japanese.

PMID:
12428367
[PubMed - indexed for MEDLINE]
15.

Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Olichney JM, Galasko D, Salmon DP, Hofstetter CR, Hansen LA, Katzman R, Thal LJ.

Neurology. 1998 Aug;51(2):351-7.

PMID:
9710002
[PubMed - indexed for MEDLINE]
16.

Contractures and loss of function in patients with Alzheimer's disease.

Souren LE, Franssen EH, Reisberg B.

J Am Geriatr Soc. 1995 Jun;43(6):650-5.

PMID:
7775724
[PubMed - indexed for MEDLINE]
17.

The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group.

Raskind MA, Cyrus PA, Ruzicka BB, Gulanski BI.

J Clin Psychiatry. 1999 May;60(5):318-25.

PMID:
10362441
[PubMed - indexed for MEDLINE]
19.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
20.

Clinical outcomes of possible versus probable Alzheimer's disease.

Villareal DT, Grant E, Miller JP, Storandt M, McKeel DW, Morris JC.

Neurology. 2003 Sep 9;61(5):661-7.

PMID:
12963758
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk